Port Delivery System with Ranibizumab (PDS) Met Primary Endpoint and Key Secondary Outcomes with > 75% of Patients Preferring PDS Treatment in Phase 3 Pavilion Trial for Diabetic Retinopathy (DR)
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined